Revolution Medicines Inc’s filing revealed that its insider GOLDSMITH MARK A unloaded Company’s shares for reported $0.35 million on Apr 10 ’24. In the deal valued at $35.33 per share,10,000 shares were sold. As a result of this transaction, GOLDSMITH MARK A now holds 30,424 shares worth roughly $1.08 million.
Then, GOLDSMITH MARK A sold 7,500 shares, generating $266,122 in total proceeds. Upon selling the shares at $35.48, the insider now owns 452,879 shares.
Before that, Patel Sushil sold 2,155 shares. Revolution Medicines Inc shares valued at $79,735 were divested by the Director at a price of $37.00 per share. As a result of the transaction, Patel Sushil now holds 15,700 shares, worth roughly $0.56 million.
Needham reiterated its Revolution Medicines Inc [RVMD] rating to a Buy in a research note published on April 12, 2024; the price target was $46. A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in early April from “an Outperform” to “a Strong buy”. Piper Sandler began covering RVMD with “an Overweight” recommendation on March 11, 2024. BofA Securities revised its rating on January 05, 2024. It rated RVMD as “a Buy” which previously was an “a Neutral”.
Price Performance Review of RVMD
On Monday, Revolution Medicines Inc [NASDAQ:RVMD] saw its stock fall -1.47% to $35.54. Over the last five days, the stock has gained 11.38%. Revolution Medicines Inc shares have risen nearly 23.92% since the year began. Nevertheless, the stocks have risen 60.31% over the past one year. While a 52-week high of $38.73 was reached on 04/11/24, a 52-week low of $15.44 was recorded on 01/18/24. SMA at 50 days reached $31.18, while 200 days put it at $28.05. A total of 1.12 million shares were traded, compared to the trading of 2.51 million shares in the previous session.
Levels Of Support And Resistance For RVMD Stock
The 24-hour chart illustrates a support level at 34.60, which if violated will result in even more drops to 33.66. On the upside, there is a resistance level at 36.52. A further resistance level may holdings at 37.49. The Relative Strength Index (RSI) on the 14-day chart is 62.42, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.50, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 34.75%. Stochastics %K at 73.97% indicates the stock is a holding.
The most recent change occurred on January 04, 2024 when Wedbush began covering the stock and recommended ‘”an Outperform”‘ rating along with a $41 price target.
